CLASSICAL 91 ONE:
Classical Music from C24
BBC World News
Brentwood-based BioMimetic has filed yet another round of paperwork in hopes of gaining federal approval for its bone graft therapy, called Augmentin.
Franklin-based BioMimetic is getting rid of a quarter of its staff.